IGFBP2 Antibodies

Santa Cruz Biotechnology delivers a wide array of IGFBP2 monoclonal antibodies for research focused on understanding Insulin-like Growth Factor Binding Protein 2. IGFBP2 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). IGFBP2 plays a critical role in regulating the availability and activity of insulin-like growth factors (IGFs), which are essential for cell growth, development, and metabolism. By binding to IGFs, IGFBP2 modulates their effects on cellular processes, influencing pathways related to growth and differentiation. Understanding IGFBP2 function is crucial for elucidating its involvement in various physiological and pathological conditions, including cancer and metabolic disorders. Researchers worldwide utilize IGFBP2 monoclonal antibodies to investigate cellular signaling pathways and protein interactions. Advanced research techniques incorporating IGFBP2 monoclonal antibodies help reveal new insights into disease mechanisms and potential therapeutic targets. The specificity and reliability of Santa Cruz Biotechnology monoclonal antibodies enable researchers to make meaningful contributions to scientific understanding of IGFBP2's role in human health and disease.